首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到19条相似文献,搜索用时 187 毫秒
1.
应用爱普利注射剂,选择自然感染线虫和体外寄生虫的1.5岁放牧藏系绵羊100只,分别按0.1、0.2、0.3 mg/kg.b w剂量皮下注射给药,同时设伊维菌素注射剂药物对照组和阳性对照组,评价驱除放牧绵羊体内线虫与体外寄生虫的效果。结果显示:爱普利注射剂0.2、0.3 mg/kg剂量对放牧绵羊消化道线虫虫卵转阴率分别为95.0%和100.0%,减少率分别为98.4%和100.0%;网尾线虫幼虫转阴率和减少率均达100.0%,原圆科线虫幼虫转阴率分别为90.0%和100.0%,减少率分别为96.1%和100.0%;对主要线虫虫卵(幼虫)的平均有效率分别达98.0%和100.0%;第7d对绵羊颚虱、足颚虱的转阴率、杀虫率均达100%;对羊蜱蝇的转阴率分别为90.0%和100.0%,杀虫率分别达92.3%和100%;均达到了高效。爱普利注射剂0.1 mg/kg剂量对线虫虫卵(幼虫)的转阴率、减少率及对体外寄生虫的杀虫率均次于0.2、0.3 mg/kg剂量组。对照药物伊维菌素注射剂0.2 mg/kg剂量消化道线虫虫卵转阴率、减少率分别为95.0%和97.8%;网尾线虫幼虫转阴率和减少率均达100.0%,原圆科线虫幼虫转阴率、减少率分别为85.0%和94.3%;第7d绵羊颚虱、足颚虱的转阴率、杀虫率均达100%;羊蜱蝇转阴率、杀虫率分别为80.0%和90%。阳性对照组线虫虫卵(幼虫)与给药前无明显变化、3种体外寄生虫感染情况较给药前略有增加。绵羊皮下注射3个剂量爱普利注射剂,未出现任何异常反应。试验证明爱普利注射剂3个剂量对藏系绵羊线虫虫卵(幼虫)、3种体外寄生虫均有效,其中0.2 mg/kg剂量驱除放牧绵羊线虫高效安全经济。  相似文献   

2.
应用埃谱利诺菌素注射剂,选择自然感染线虫的1岁藏系绵羊150只,分别按0.1、0.2、0.3 mg/kg体重剂量皮下注射给药,驱除藏羊线虫,同时设伊维菌素注射剂药物对照组和阳性对照组。结果显示:①埃谱利诺菌素注射剂0.2、0.3 mg/kg体重剂量对藏羊消化道线虫虫卵转阴率分别为93.3%和100.0%,减少率分别为99.18%和100.0%;对网尾线虫幼虫转阴率和减少率均达100.0%,原圆科线虫幼虫转阴率分别为90.0%、100.0%,减少率分别为95.79%和100.0%;对线虫成虫的总计驱虫率分别为98.83%和99.96%,对线虫寄生阶段幼虫的总计驱虫率分别为96.42%和99.17%。②0.1 mg/kg剂量对线虫虫卵(幼虫)的转阴率、减少率、驱虫率均次于0.2、0.3 mg/kg体重剂量组。③对照药物伊维菌素注射剂0.2 mg/kg体重剂量对消化道线虫、原圆科线虫幼虫转阴率和减少率、对线虫成虫及其寄生阶段幼虫的总计驱虫率与同剂量埃谱利诺菌素注射剂基本一致。④藏羊皮下注射试验剂量未出现任何异常反应。试验证明埃谱利诺菌素注射剂0.2 mg/kg体重剂量驱除线虫高效安全。  相似文献   

3.
伊维菌素浇泼剂对绵羊线虫的驱虫效力与安全性试验   总被引:3,自引:0,他引:3  
应用0.5%伊维菌素浇泼剂按0.3,0.4,0.5mg/kg.b w剂量对绵羊沿背中线皮肤一次浇泼给药,并以伊维菌素注射剂0.2mg/kg.b w剂量做对照。结果:伊维菌素浇泼剂0.3mg/kg,0.4mg/kg.b w剂量对消化道线虫虫卵转阴率分别为85%和90%,减少率分别为89.1%和95.9%;对原圆科线虫幼虫转阴率分别为60%和75%,减少率分别为77.2%和86.7%;0.5mg/kg.b w剂量对消化道线虫虫卵转阴率和减少率均为100%,对原圆科线虫幼虫转阴率为85%,减少率为95.4%。解剖检查结果:伊维菌素浇泼剂三种剂量对绵羊消化道、呼吸道多属线虫均有效,总计驱虫率分别为90.8%,95.6%和99.7%,伊维菌素浇泼剂0.5mg/kg.b w剂量与伊维菌素注射剂0.2mg/kg.b w剂量驱虫效果基本一致;绵羊经皮给药可耐受1.0mg/kg.b w剂量。试验证明:伊维菌素浇泼剂经皮给药驱除绵羊线虫高效安全,临床推荐剂量以0.5mg/kg.b w为宜。  相似文献   

4.
应用伊维菌素注射剂,按0.2mg/kg体重剂量皮下注射给药,进行牦牛寄生虫病防治,评价对牦牛体内线虫和体外寄生虫的疗效.结果:对牦牛主要7属消化道线虫和网尾线虫的虫卵(幼虫)转阴率、减少率均达100%;毛首线虫的驱虫率86.4%;对线虫的总计驱虫率99.3%;对绵羊颚虱的杀虫率达100%.技术示范群比阳性对照群牦牛平均多增重3.9kg,幼年牦牛成活率提高1.9个百分点.示范结果证明:伊维菌素注射剂0.2mg/kg剂量一次给药,驱除牦牛体内线虫和体外虱、蝇等寄生虫,高效安全,生产效益显著.  相似文献   

5.
为评价埃谱利诺菌素注射剂的驱虫药效与对放牧绵羊线虫病及外寄生虫病的防治示范应用效果,选择1.5岁感染线虫和部分外寄生虫的绵羊150只,设埃谱利诺菌素注射剂0.1,0.2和0.3 mg/kg体重剂量组和埃谱利诺菌素原料药对照组,进行驱虫效果评价,按0.2 mg/kg体重剂量进行规模防治技术示范,检查防治效果和考核防治效益。结果:药效试验中埃谱利诺菌素注射剂0.2 mg/kg剂量对绵羊消化道线虫虫卵转阴率和减少率分别为96.7%和99.3%,对原圆科线虫幼虫转阴率和减少率分别为90.0%和97.5%;0.3 mg/kg剂量对消化道线虫虫卵及原圆科线虫幼虫转阴率和减少率均为100.0%;0.1mg/kg剂量对消化道线虫虫卵转阴率和减少率分别为83.3%和90.4%,原圆科线虫幼虫转阴率和减少率分别为76.7%和88.9%。在冬季应用埃谱利诺菌素注射剂按0.2 mg/kg体重剂量对放牧绵羊进行规模防治技术示范,防治示范群绵羊消化道线虫虫卵转阴率和减少率分别为96.7%和97.7%;对原圆科线虫幼虫转阴率和减少率分别为93.3%和97.6%。同期检查未防治对照组绵羊虫卵EPG和幼虫数略有增加。埃谱利诺菌素注射剂0.2mg/kg剂量试验组给药后第1d绵羊体表的绵羊颚虱、足颚虱、羊蜱蝇活力旺盛;第3d绵羊颚虱、足颚虱大部分死亡干瘪,部分虫体移行到被毛表面,处于麻痹状态,活力较差;第7d检查对足颚虱的杀虫率达100%;绵羊颚虱全部死亡干瘪,杀虫率达100%;对羊蜱蝇的转阴率为83.3%。0.1mg/kg剂量,第3、7d检查杀灭效果次于上述剂量。未防治的对照组绵羊上述外寄生虫活力旺盛,感染情况与给药前无明显变化。同期检查技术示范群比未示范群每只成年羊平均少减重5.96kg、幼年羊成活率平均提高2.35个百分点。结果表明该防治技术对放牧绵羊主要寄生虫病高效安全,效益显著。  相似文献   

6.
应用伊维菌素干混悬剂进行了驱除猪蛔虫的效力及安全性试验。结果:0.3mg/kg b.w剂量对猪蛔虫的虫卵转阴率、虫卵减少率和驱虫率均达100%,猪可耐受1.5mg/kg剂量。试验证明伊维菌素干混悬剂驱除猪蛔虫安全高效,投药方便,成本较低,具有推广前景。  相似文献   

7.
为了验证两种常用驱虫药对猪蛔虫病的疗效,采用临床诊断和实验室诊断相结合的方法,对在兽医临床中遇到的规模养猪户发生的猪蛔虫病进行了诊断,应用阿苯达唑、伊维菌素进行对猪自然感染寄生虫驱虫效果观察。结果:阿苯达唑10mg/kg剂量一次口服给药后7d的虫卵转阴率、减少率分别为86.67%和91.47%;伊维菌素注射剂0.2mg/kg剂量组消化道线虫虫卵转阴率、减少率分别为93.33%和95.66%;阳性对照组两次粪检,其EPG第二次比第一次略有增加。结果表明阿苯达唑10mg/kg剂量、伊维菌素0.2mg/kg剂量驱除猪蛔虫高效安全。  相似文献   

8.
本研究评价了埃普利诺菌素注射剂、浇泼剂对牦牛主要寄生虫病的驱虫疗效,为建立牦牛主要寄生虫病高效低残留防治技术提供依据。选用自然感染线虫、牛颚虱和皮蝇蛆的牦牛,采用粪检法和剖检法进行驱虫疗效试验。结果:埃普利诺菌素注射剂0. 1,0. 2,0. 3mg/kg剂量组消化道线虫虫卵转阴率分别为85. 0%,95. 0%和100. 0%,减少率分别为91. 9%,98. 4%和100. 0%。0. 2,0. 3mg/kg剂量组对牦牛网尾线虫L1转阴率和减少率均达100. 0%。0. 1mg/kg剂量组L1转阴率和减少率分别为90. 0%和95. 2%。0. 2,0. 3mg/kg剂量组原圆线虫L1转阴率分别为93. 3%,100. 0%,减少率分别为98. 3%,100. 0%。0. 1mg/kg剂量组L1转阴率和减少率分别为80. 0%,88. 5%。3个试验组对线虫成虫的总计驱虫率分别为90. 5%,97. 2%和99. 5%。埃普利诺菌素注射剂0. 3mg/kg剂量组给药后3d牛颚虱大部分死亡干瘪,第7d全部死亡干瘪,驱虫率均达100. 0%。0. 1mg/kg剂量组低剂量组的杀虫效果次于上述剂量。0. 2mg/kg剂量组与IVM注射剂0. 2mg/kg体重剂量组驱虫效果无显著差异。3个剂量组对牦牛皮蝇蛆的驱净率、驱虫率均达100. 0%;埃普利诺菌素浇泼剂0. 4mg/kg剂量组对牦牛消化道线虫的虫卵转阴率、减少率分别为95. 0%和96. 4%~98. 3%。对牛颚虱和皮蝇蛆的驱杀效率均为100%。0. 5mg/kg剂量组对牦牛消化道线虫的虫卵转阴率、减少率均达100. 0%,对牛颚虱和皮蝇蛆的杀虫效果均达100%,对牛颚虱与牦牛体内消化道线虫持效期至少为28d。研究结果表明,埃普利诺菌素注射剂、浇泼剂对牦牛线虫病、牛颚虱与牛皮蝇蛆病等主要寄生虫病的驱虫疗效高,有很好的控制效果。  相似文献   

9.
伊维菌素泼背剂对牦牛寄生虫的驱除效果试验   总被引:2,自引:0,他引:2  
为选择适应于高寒牧区放牧牦牛大群驱除体内外寄生虫的理想荆型,在青海大通种牛场通过粪检选60头牦牛,随机分为3组,每组20头,试验1组用伊维菌素泼背荆接0.5 mg/kg体重剂量经背部皮肤浇泼给药,试验2组用伊维菌素注射剂按0.2 mg/kg体重剂量经皮下注射给药,试验3组为空白对照组.分析了三组不同寄生虫卵转率、虫卵减少率及驱虫率指标的变化,同时对药物的安全性进行了观察.结果试验1组消化道线虫虫卵转阴率、减少率分别为90%和99.1%,原圆科线虫幼虫转阴率、减少率分别为80%和92.8%;线虫成虫、寄生阶段幼虫的总计驱虫率分别为99.3%和98.8%;试验2组相应指标分别为90%和98.7%、80%和92.9%、99.4%和99.2%;1.2组对牛颚虱杀虫率均达100%,但对莫尼茨绦虫无效,对照组体内外寄生虫均无明显变化.表明伊维菌素泼背剂0.5 mg/kg剂量安全,驱虫效果可信,可在青海高寒地区牦牛体内外寄生虫驱虫工作中推广应用.  相似文献   

10.
阿维菌素和丙硫苯咪唑对巨晰体内寄生虫的驱除试验   总被引:1,自引:0,他引:1  
用丙硫苯咪唑和阿维菌素对国家一级保护野生动物巨蜥进行驱进行驱虫试验,每种药物设2个剂量组,每组6个重复。口服丙硫苯咪唑40.0mg/kg剂量组的胃肠道线虫虫卵减少率和虫卵转阴率分别为91.49%和83.33%,20.0mg/kg的剂量无效。皮下注射阿维菌素0.3mg/kg和0.6mg/kg剂量组的胃肠道线虫虫卵减少率和虫卵阴率均达100%。试验结果表明,用丙硫苯咪唑驱除巨蜥消化道线虫需较高剂量,较小剂量的阿维菌素对驱除巨蜥消化道线虫效果很好。  相似文献   

11.
伊维菌素浇泼剂治疗猪蛔虫及血虱的驱除效果   总被引:1,自引:0,他引:1  
应用0.5%伊维菌素浇泼剂进行了驱除猪血虱和猪蛔虫的试验。结果:给药后第7d对猪血虱的转阴率达100%;第15d对猪蛔虫的驱虫率达到100%,表明0.5%伊维菌素浇泼剂对驱除猪蛔虫和血虱是高效安全的。  相似文献   

12.
Faecal samples were collected from a total of 1,000 pigs from the Port Harcourt and Jos areas of the Rivers and Plateau States, respectively, between January 1987 and March 1988. In the Jos area the parasite incidence was: Ascaris suum 53.1%, Trichuris suis 8.5%, Hyostrongylus rubidus 13.1%, Metastrongylus salmi 3.7%, Strongyloides ransomi 87.7%, Oesophagostomum dentatum 35.1% and Eimeria spp. 2.4% while in Port Harcourt the incidence rate was Ascaris suum 10.4%, Trichuris suis 47.2%, Oesophagostomum dentatum 50%, Hyostrongylus rubidus 2%, Ancylostoma duodenale 83.2% and Eimeria spp. 3.6%. The high rate of parasitic infections was due to poor management practices as shown by poor sanitary conditions. Access to human faeces, poor feeding and lack of deworming were also very evident. The different rates in the incidence of parasites in Jos and Port Harcourt areas were due to the varying moisture conditions in these states.  相似文献   

13.
Fenbendazole was given in the feed to swine at a cumulative dosage of 9 mg/kg of body weight over a period of 3, 6, and 12 days to compare efficacy. Four treatment groups of ten 2- to 3-month-old pigs each, with a mean of 15 kg of body weight per group, received 3 mg of fenbendazole/kg/day for 3 days, 1.5 mg/kg/day for 6 days, 0.75 mg/kg/day for 12 days, and no medication. Medicated feed was scheduled so that all treated pigs reached the last day of treatment on the same day, thus making the time between the last treatment and necropsy equal for all groups. Ascaris suum and Trichuris suis were the target species, their presence before treatment being determined by fecal egg counts and at necropsy by worm counts. At necropsy, 9 control pigs were infected with A suum (mean of 18.0 worms/pig), and all control pigs had T suis infection (mean of 36.5 worms/pig). All 3 treatment schedules were 100% effective in removal of A suum; and for T suis, the 3-day regimen was 100% effective, the 6-day regimen, 99.2%, and the 12-day regimen, 91.0%.  相似文献   

14.
Oxfendazole, a benzimidazole carbamate, was administered as a 0.5% feed additive to 88 pigs naturally infected with two to four nematode species. Dose rates of 1.5 mg/kg of body weight, 3.0 mg/kg, 3.75 mg/kg, 4.5 mg/kg, 6.75 mg/kg, or 9.0 mg/kg were 100% efficacious against Oesophagostomum dentatum and 99.2% to 100% effective against Ascaris suum. Dose rates of 4.5 mg/kg, 6.75 mg/kg, and 9.0 mg/kg were 92.7%, 98.9%, and 99.5% effective, respectively, against mixed populations of Metastrongylus apri and M pudendotectus. Results were variable with Trichuris suis infections. Efficacy was based on the number of nematodes recovered at necropsy. Palatability and acceptability of the feed additive were good, and adverse reactions following administration were not observed.  相似文献   

15.
The efficacy of ivermectin as an in-feed formulation was evaluated against naturally acquired gastrointestinal helminths, lungworms, and sarcoptic mites (experiment 1; n = 24) and against induced infection with intestinal nematodes (experiment 2; n = 24) in pigs. Treatments consisted of ivermectin administered in feed at concentrations calculated to provide 100 or 200 micrograms/kg of body weight/d for 7 days or of nonmedicated feed (controls) for 7 days. At concentration of 100 micrograms of ivermectin/kg/d, efficacy against naturally acquired infections was 97.7% for Ascaris suum, 97.8% for Metastrongylus spp, greater than 99% for Oesophagostomum spp, 100% for Macracanthorhynchus hirudinaceus, and 89.7% for Ascarops strongylina. Against induced infections (fourth-stage larvae), efficacy was 100% for A suum and 96.9% for Oesophagostomum spp. At concentration of 200 micrograms of ivermectin/kg/d, efficacy against naturally acquired infections was 100% for A suum, Hyostrongylus rubidus, Metastrongylus spp, and Ascarops strongylina; greater than 99% for Oesophagostomum spp; and 85.9% for Macracanthorhynchus hirudinaceus. Against induced infections (fourth-stage larvae), efficacy was 100% for A suum and 95% for Oesophagostomum spp. At concentrations of 100 and 200 micrograms of ivermectin/kg/d, efficacy against Sarcoptes scabiei var suis was evidenced by elimination of the mite by posttreatment day 14.  相似文献   

16.
Mebendazole, administered at a dose of 30 mg active substance per 1 kg of feed, was found to have 100% effectiveness on Ascaris suum and Cambendazole, administered at a dose of 1.5 g per 1 kg of liver weight, showed the same effectiveness in the control of Ascaris suum and Oesophagostomum dentatum. The effectiveness of both drugs on Trichocephalus suis and Strongyloides ransomi was low. Mebendazole and Cambendazole can be recommended for mass dehelminthization of pigs in affected stocks. Helminthoovoscopical examination of sows and fattened pigs showed an 88.6% extensity of invasion in sows, and a 28.3% and 33.9% extensity in three- and five-month-old pigs, respectively. Coccidiosis was found in 51.4% of the sows and Balantidium coli had an occurrence rate of 80.7 to 98.2%.  相似文献   

17.
Anthelmintic efficacies of dichlorvos, fenbendazole, and ivermectin were compared in specific-pathogen-free crossbred weanling pigs inoculated with Ascaris suum, Trichuris suis, and Oesophagostomum dentatum. On postinoculation day (PID) 50, 24 pigs in each treatment group were treated orally with 43 mg of dichlorvos/kg of body weight, 3 X 3 mg of fenbendazole/kg, or 300 micrograms of ivermectin/kg, SC. Twenty-four pigs were not treated. On posttreatment day 7 (PID 57), 12 pigs from each treatment group (phase I) were slaughtered, and the anthelmintic efficacy of each treatment was determined. Efficacies against A suum, T suis, and O dentatum, respectively, were: dichlorvos, 100%, 99.9%, and 100%; fenbendazole, 100%, 99.8%, and 100%; and ivermectin, 98.7%, 53.9%, and 87.6%. Weight gains and feed conversions of the remaining pigs were monitored until they reached market weight (phase II). The average weight gains (kg) and feed conversions (kg of feed/kg of gain) at posttreatment day 81 (PID 131), respectively, were: 73.6 and 3.44 for nontreated controls, 78.9 and 3.31 for dichlorvos-treated pigs, 72.1 and 3.36 for fenbendazole-treated pigs, and 74 and 3.48 for ivermectin-treated pigs. Differences in average weight gains and feed conversions were not significant (P greater than 0.05).  相似文献   

18.
A controlled trial was performed to evaluate the efficacy of piperazine dihydrochloride in a new granular formulation (Ascarex D) against naturally occurring infections with Ascaris suum, Oesophagostomum dentatum and O quadrispinulatum. Treatment effects were estimated on the basis of parasites recoverable from the intestinal contents. Given orally at 200 mg per kg body weight the compound showed an efficacy of 99 to 100 per cent against A suum and the nodular worms. Egg excretion of the respective species was reduced by 98 per cent and 100 per cent six days after treatment. No adverse reactions were observed after the treatment.  相似文献   

19.
云南使君子提取物作为实验用药,对感染猪蛔虫的动物进行了药效实验研究。结果使君子提取物给药最佳剂量为0.05mg/kg。粪检虫卵数计数表明,每克粪便虫卵数与用药前相比存在差异显著性(P〈0.05)。所检测的血液生化指标在给药前后均没有出现显著性的变化(P〉0.05)。从而可初步推断使君子提取物对猪的肝脏、肾脏、心脏和肌肉等组织器官没有产生明显的影响。使君子提取物对猪蛔虫有较好的驱虫效果,且毒副作用小。  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号